首页 > 最新文献

Digital Chinese Medicine最新文献

英文 中文
A new interpretation of TCM pulse diagnosis based on quantum physical model of the human body 基于人体量子物理模型的中医脉诊新解释
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.1016/j.dcmed.2022.12.009
Shuna SONG, Zhensu SHE

Following the quantum theory-based physical model of the human body, a new interpretation of the traditional Chinese medicine (TCM) principle of “Cunkou reads viscera” is presented. Then, a Gaussian pulse wave model as a solution to the Schrodinger equation is shown to accurately describe 19 different pulse shapes, and to quantitatively capture the degree of Yin-Yang attributes of 13 pulse shapes. Furthermore, the model suggests using pulse depth and strength as leading-order quantity and pulse shape as first-order quantity, to characterize the hierarchical resonance between the human body and the environment. The future pulse informatics will focus on determining an individual’s unique quantum human equilibrium state, and diagnose its health state according to the pulse deviation from its equilibrium state, to truly achieve the high level of TCM: “knowing the normal state and reaching the change”.

根据基于量子理论的人体物理模型,对“存口读脏腑”的中医原理进行了新的解释。然后,用高斯脉冲波模型作为薛定谔方程的解,准确地描述了19种不同的脉冲形状,并定量地捕捉了13种脉冲形状的阴阳属性程度。此外,该模型建议使用脉冲深度和强度作为第一阶量,脉冲形状作为一阶量来表征人体与环境之间的层次共振。未来的脉冲信息学将专注于确定个体独特的量子人体平衡状态,并根据脉冲偏离平衡状态来诊断其健康状态,真正达到中医的高水平:“知正常,达变化”。
{"title":"A new interpretation of TCM pulse diagnosis based on quantum physical model of the human body","authors":"Shuna SONG,&nbsp;Zhensu SHE","doi":"10.1016/j.dcmed.2022.12.009","DOIUrl":"10.1016/j.dcmed.2022.12.009","url":null,"abstract":"<div><p>Following the quantum theory-based physical model of the human body, a new interpretation of the traditional Chinese medicine (TCM) principle of “Cunkou reads viscera” is presented. Then, a Gaussian pulse wave model as a solution to the Schrodinger equation is shown to accurately describe 19 different pulse shapes, and to quantitatively capture the degree of Yin-Yang attributes of 13 pulse shapes. Furthermore, the model suggests using pulse depth and strength as leading-order quantity and pulse shape as first-order quantity, to characterize the hierarchical resonance between the human body and the environment. The future pulse informatics will focus on determining an individual’s unique quantum human equilibrium state, and diagnose its health state according to the pulse deviation from its equilibrium state, to truly achieve the high level of TCM: “knowing the normal state and reaching the change”.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000799/pdfft?md5=ca094b5578857d4b8e10fa4721ab0df4&pid=1-s2.0-S2589377722000799-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75263822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Molecular modeling of alkaloids bouchardatine and orirenierine binding to sirtuin-1 (SIRT1) 生物碱bouchardatine和orirenierine与SIRT1结合的分子模拟
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.004
Gérard Vergoten , Christian Bailly

Objective

Bouchardatine (1) is a β-indoloquinazoline alkaloid isolated from the plant Bouchardatia neurococca, acting as a modulator of adipogenesis and lipogenesis, and as an anticancer agent. The natural product functions as an activator of proteins adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK) and sirtuin 1 (SIRT1). We used molecular modeling to investigate the SIRT1-binding capacity of compound 1 and various structural analogues, such as orirenierine A (2) and orirenierine B (3) isolated from the medicinal plant Oricia renieri.

Methods

We investigated the binding to human SIRT1 (hSIRT1) of 25 natural products including the β-indoloquinazoline alkaloids 13 and analogues, in comparison with the reference product sirtinol (R and S isomers). A sirtinol binding model was elaborated starting from the closed and open state conformations of the catalytic domain of hSIRT1 (PDB structures 4KXQ and 4IG9). For each compound bound to SIRT1, the empirical energy of interaction (ΔE) was calculated and compared to that of sirtinol.

Results

In our model, compound1 was found to bind modestly to the sirtinol site of SIRT1. In contrast, the presence of a phenolic OH group at position 7 on the quinazolinone moiety conferred a much higher binding capacity. Compound 2 provided SIRT1 protein complexes as stable as those observed with sirtinol. The replacement of the hydroxy substituent (2) with a methoxy group (3) reduced the SIRT1 binding capacity. Other SIRT1-binding natural products were identified, such as the alkaloids orisuaveolines A and B. Structure-binding relationships were discussed.

Conclusion

The study underlines the capacity of β-indoloquinazoline alkaloids to interact with SIRT1. This deacetylase enzyme could represent a molecular target for the alkaloid 2. This compound merits further attention for the design of drugs active against SIRT1-dependent pathologies.

目的布chardatine(1)是从植物布chardatia neurococca中分离出来的β-吲哚喹唑啉类生物碱,具有脂肪生成和脂肪生成的调节剂和抗癌作用。这种天然产物的功能是作为腺苷5 ' -单磷酸腺苷(AMP)活化蛋白激酶(AMPK)和sirtuin 1 (SIRT1)的激活剂。我们利用分子模型研究了从药用植物鸢尾中分离的化合物1和不同的结构类似物,如orirenierine A(2)和orirenierine B(3)的sirt1结合能力。方法研究了β-吲哚喹唑啉生物碱1−3及其类似物等25种天然产物与人SIRT1 (SIRT1)的结合情况,并与对照品sirtinol (R和S异构体)进行比较。从sihrt1催化结构域(PDB结构4KXQ和4IG9)的闭合和开放状态构象出发,阐述了sirtinol结合模型。对于每个与SIRT1结合的化合物,计算其经验相互作用能(ΔE),并与sirtinol进行比较。结果在我们的模型中,化合物1被发现与SIRT1的sirtinol位点适度结合。相比之下,在喹唑啉酮部分的7号位置上存在酚羟基赋予了更高的结合能力。化合物2提供与sirtinol一样稳定的SIRT1蛋白复合物。用甲氧基(3)取代羟基取代基(2)降低了SIRT1的结合能力。其他与sirt1结合的天然产物也被鉴定出来,如生物碱orisuaveoline A和b。结论β-吲哚喹唑啉类生物碱具有与SIRT1相互作用的能力。这种去乙酰化酶可能代表生物碱2的分子靶标。该化合物值得进一步关注,以设计抗sirt1依赖性病理的药物。
{"title":"Molecular modeling of alkaloids bouchardatine and orirenierine binding to sirtuin-1 (SIRT1)","authors":"Gérard Vergoten ,&nbsp;Christian Bailly","doi":"10.1016/j.dcmed.2022.10.004","DOIUrl":"10.1016/j.dcmed.2022.10.004","url":null,"abstract":"<div><h3>Objective</h3><p>Bouchardatine (<strong>1</strong>) is a <em>β</em>-indoloquinazoline alkaloid isolated from the plant <em>Bouchardatia neurococca</em>, acting as a modulator of adipogenesis and lipogenesis, and as an anticancer agent. The natural product functions as an activator of proteins adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK) and sirtuin 1 (SIRT1). We used molecular modeling to investigate the SIRT1-binding capacity of compound <strong>1</strong> and various structural analogues, such as orirenierine A (<strong>2</strong>) and orirenierine B (<strong>3</strong>) isolated from the medicinal plant <em>Oricia renieri</em>.</p></div><div><h3>Methods</h3><p>We investigated the binding to human SIRT1 (hSIRT1) of 25 natural products including the <em>β</em>-indoloquinazoline alkaloids <strong>1</strong> − <strong>3</strong> and analogues, in comparison with the reference product sirtinol (<em>R</em> and <em>S</em> isomers). A sirtinol binding model was elaborated starting from the closed and open state conformations of the catalytic domain of hSIRT1 (PDB structures 4KXQ and 4IG9). For each compound bound to SIRT1, the empirical energy of interaction (<em>Δ</em>E) was calculated and compared to that of sirtinol.</p></div><div><h3>Results</h3><p>In our model, compound<strong>1</strong> was found to bind modestly to the sirtinol site of SIRT1. In contrast, the presence of a phenolic OH group at position 7 on the quinazolinone moiety conferred a much higher binding capacity. Compound <strong>2</strong> provided SIRT1 protein complexes as stable as those observed with sirtinol. The replacement of the hydroxy substituent (<strong>2</strong>) with a methoxy group (<strong>3</strong>) reduced the SIRT1 binding capacity. Other SIRT1-binding natural products were identified, such as the alkaloids orisuaveolines A and B. Structure-binding relationships were discussed.</p></div><div><h3>Conclusion</h3><p>The study underlines the capacity of <em>β</em>-indoloquinazoline alkaloids to interact with SIRT1. This deacetylase enzyme could represent a molecular target for the alkaloid <strong>2</strong>. This compound merits further attention for the design of drugs active against SIRT1-dependent pathologies.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000519/pdfft?md5=8719fda5424ec12da1152c2e2f54fe34&pid=1-s2.0-S2589377722000519-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81608525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chaihu Longgu Muli Decoction relieving temporal lobe epilepsy in rats by inhibiting TLR4 signaling pathway through miR-146a-3p and miR-146a-5p 柴胡龙骨木里汤通过miR-146a-3p和miR-146a-5p抑制TLR4信号通路缓解大鼠颞叶癫痫
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.008
Mao Yizhi , Li Liang , Luo Zhihong , Huang Yahui , Wu Huaying , Yang Ping , Peng Qinghua

Objective

To explore the effect and mechanism of Chaihu Longgu Muli Decoction (柴胡龙骨牡蛎汤, CHLGMLD) in rats with temporal lobe epilepsy (TLE).

Methods

A total of 80 Sprague-Dawley (SD) male rats were randomized into control (CON), model (MOD), carbamazepine (CBZ, 0.1 g/kg), CHLGMLD low dose (CHLGMLD-L, 12.5 g/kg), and high dose (CHLGMLD-H, 25 g/kg) groups, with 16 rats in each group. TLE rat models were established in the four groups with the use of lithium-pilocarpine except for the CON group. After the successful establishment of TLE models, all drugs were administered through gavage, and distilled water was given to rats in the CON and MOD groups for four weeks. The frequency and duration of seizures before and after treatment were recorded for the evaluation of the alleviation degree. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression levels of miR-146a-3p and miR-146a-5p. The expression levels of toll-like receptor 4 (TLR4), interleukin-1 receptor-associated kinase 1 (IRAK1), tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), TAK1-binding protein (TAB), nuclear factor-kappa B (NF-κB), and interleukin-1 beta (IL-1β) in hippocampus were tested by immunofluorescence assay. Correlation analysis between the above factors and expressions of miR-146a-3p and miR-146a-5p were performed separately.

Results

CHLGMLD decreased the frequency (P < 0.05) and duration (P < 0.01) of seizures in rats. CHLGMLD down-regulated the expression levels of miR-146a-5p and miR-146a-3p (P < 0.05), and inhibited the expression levels of TLR4, IRAK1, TRAF6, TAB, NF-κB, and IL-1β (P < 0.01). The correlation analysis revealed that the expression levels of TLR4, IRAK1, TRAF6, TAB, NF-κB, and IL-1β were positively correlated with the expression levels of miR-146a-3p and miR-146a-5p detected by qRT-PCR, respectively (P < 0.01).

Conclusion

CHLGMLD can inhibite the TLR4 signaling pathway by lowering the expression levels of miR-146a-3p and miR-146a-5p to alleviate hippocampal dentate gyrus inflammation in TLE rats, thus relieving seizures.

目的探讨柴胡龙骨木里汤对颞叶癫痫(TLE)大鼠的治疗作用及其机制。方法将80只SD雄性大鼠随机分为对照组(CON)、模型组(MOD)、卡马西平(CBZ, 0.1 g/kg)、CHLGMLD低剂量组(CHLGMLD- l, 12.5 g/kg)、高剂量组(CHLGMLD- h, 25 g/kg),每组16只。除CON组外,其余4组均采用锂-匹罗卡品建立TLE大鼠模型。TLE模型建立成功后,所有药物均通过灌胃给药,CON组和MOD组大鼠给予蒸馏水,持续4周。记录治疗前后癫痫发作次数和持续时间,评价缓解程度。采用实时定量聚合酶链反应(qRT-PCR)检测miR-146a-3p和miR-146a-5p的表达水平。免疫荧光法检测海马组织中toll样受体4 (TLR4)、白细胞介素-1受体相关激酶1 (IRAK1)、肿瘤坏死因子(TNF)受体相关因子6 (TRAF6)、tak1结合蛋白(TAB)、核因子κB (NF-κB)、白细胞介素-1β (IL-1β)的表达水平。分别分析上述因素与miR-146a-3p、miR-146a-5p表达的相关性。ResultsCHLGMLD频率降低(P & lt;0.05)和持续时间(P <0.01)。CHLGMLD下调miR-146a-5p和miR-146a-3p的表达水平(P <0.05),抑制TLR4的表达水平,IRAK1, TRAF6,选项卡,NF -κB, il - 1β(P & lt;0.01)。相关性分析表明TLR4的表达水平,IRAK1, TRAF6,选项卡,NF -κB,和il - 1β的表达水平呈正相关,mir - 146 - a - 3 - P和mir - 146 - 5 - P检测到存在,(分别P & lt;0.01)。结论chlgmld可通过降低miR-146a-3p和miR-146a-5p的表达水平,抑制TLR4信号通路,减轻TLE大鼠海马齿状回炎症,从而减轻癫痫发作。
{"title":"Chaihu Longgu Muli Decoction relieving temporal lobe epilepsy in rats by inhibiting TLR4 signaling pathway through miR-146a-3p and miR-146a-5p","authors":"Mao Yizhi ,&nbsp;Li Liang ,&nbsp;Luo Zhihong ,&nbsp;Huang Yahui ,&nbsp;Wu Huaying ,&nbsp;Yang Ping ,&nbsp;Peng Qinghua","doi":"10.1016/j.dcmed.2022.10.008","DOIUrl":"10.1016/j.dcmed.2022.10.008","url":null,"abstract":"<div><h3>Objective</h3><p>To explore the effect and mechanism of Chaihu Longgu Muli Decoction (柴胡龙骨牡蛎汤, CHLGMLD) in rats with temporal lobe epilepsy (TLE).</p></div><div><h3>Methods</h3><p>A total of 80 Sprague-Dawley (SD) male rats were randomized into control (CON), model (MOD), carbamazepine (CBZ, 0.1 g/kg), CHLGMLD low dose (CHLGMLD-L, 12.5 g/kg), and high dose (CHLGMLD-H, 25 g/kg) groups, with 16 rats in each group. TLE rat models were established in the four groups with the use of lithium-pilocarpine except for the CON group. After the successful establishment of TLE models, all drugs were administered through gavage, and distilled water was given to rats in the CON and MOD groups for four weeks. The frequency and duration of seizures before and after treatment were recorded for the evaluation of the alleviation degree. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression levels of miR-146a-3p and miR-146a-5p. The expression levels of toll-like receptor 4 (TLR4), interleukin-1 receptor-associated kinase 1 (IRAK1), tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), TAK1-binding protein (TAB), nuclear factor-kappa B (NF-<em>κ</em>B), and interleukin-1 beta (IL-1<em>β</em>) in hippocampus were tested by immunofluorescence assay. Correlation analysis between the above factors and expressions of miR-146a-3p and miR-146a-5p were performed separately.</p></div><div><h3>Results</h3><p>CHLGMLD decreased the frequency (<em>P</em> &lt; 0.05) and duration (<em>P</em> &lt; 0.01) of seizures in rats. CHLGMLD down-regulated the expression levels of miR-146a-5p and miR-146a-3p (<em>P</em> &lt; 0.05), and inhibited the expression levels of TLR4, IRAK1, TRAF6, TAB, NF-<em>κ</em>B, and IL-1<em>β</em> (<em>P</em> &lt; 0.01). The correlation analysis revealed that the expression levels of TLR4, IRAK1, TRAF6, TAB, NF-<em>κ</em>B, and IL-1<em>β</em> were positively correlated with the expression levels of miR-146a-3p and miR-146a-5p detected by qRT-PCR, respectively (<em>P</em> &lt; 0.01).</p></div><div><h3>Conclusion</h3><p>CHLGMLD can inhibite the TLR4 signaling pathway by lowering the expression levels of miR-146a-3p and miR-146a-5p to alleviate hippocampal dentate gyrus inflammation in TLE rats, thus relieving seizures.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000556/pdfft?md5=0a656cc8a477e44d498d4407dd7c5988&pid=1-s2.0-S2589377722000556-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83550971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Nuc-mtDNA and DNA methylation analysis in life science and medical studies Nuc-mtDNA和DNA甲基化分析在生命科学和医学研究中的应用
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.011
Zhang Jia , L.I. Kai , Liao Duanfang
{"title":"Application of Nuc-mtDNA and DNA methylation analysis in life science and medical studies","authors":"Zhang Jia ,&nbsp;L.I. Kai ,&nbsp;Liao Duanfang","doi":"10.1016/j.dcmed.2022.10.011","DOIUrl":"10.1016/j.dcmed.2022.10.011","url":null,"abstract":"","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000581/pdfft?md5=30e84bab4b7e9664a07dc10bfa3320a5&pid=1-s2.0-S2589377722000581-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77327456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Visual analysis of research hotspots and trends in the treatment of immune thrombocytopenia with traditional Chinese medicine 中医药治疗免疫性血小板减少症的研究热点与趋势可视化分析
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.009
Gao Yao , Wu Zhenhui , Wu Min , Abid Naeem , Li Weizhizi , Zhang Daling , Liu Fan , Zeng Yingjian

Objective

Through bibliometrics and visual analysis of the related studies on traditional Chinese medicine (TCM) treatment of immune thrombocytopenia (ITP), this study aims to sort out the overall research progress, hotspots, and trends in this field, and provide reference for further research in ITP.

Methods

The articles on ITP treated by TCM were retrieved from China National Knowledge Infrastructure (CNKI), Wanfang Database, China Science and Technology Journal Database (VIP), Web of Science Core Collection (WOSCC), and PubMed. The retrieval time was from the establishment of the databases to July 31, 2022. VOSviewer, CiteSpace, Carrot2, and NoteExpress were used for data analysis of the articles in terms of their quantities, types, and journals, and for visualization of research hotspots, authors, institutions, and keywords.

Results

1 493 Chinese articles and 40 English articles were included. The articles in Chinese mainly focus on clinical trial research and clinical experience summary, while the English articles mainly focus on clinical trial research and animal research. The Chinese articles were published in 317 Chinese journals, while English articles were published in 29 English journals. Research hotspots include the clinical syndrome differentiation of ITP, the therapeutic effect of TCM compounds on ITP, and the mechanism of ITP treatment. Keyword analysis shows that there are many research achievements in integrated traditional Chinese and western medicine treatment, clinical research, famous doctors’ experience, TCM treatment, cellular immunity, and humoral immunity. The authors with the most articles in Chinese and English are Professor CHEN Xinyi and Professor MA Rou, respectively, and the research institutions with the most articles are Dongzhimen Hospital of Beijing University of Chinese Medicine and Xiyuan Hospital of China Academy of Chinese Medical Sciences. Chinese herbs often used to treat ITP clinically include Xianhecao (Agrimoniae Herba), Nvzhenzi (Ligustri Lucidi Fructus), Mohanlian (Ecliptae Herba), Zhongjiefeng (Sarcandrae Herba), etc., and the prescription usually used to treat ITP include Guipi Decoction (归脾汤), Xijiao Dihuang Decoction (犀角地黄汤), Bazhen Decoction (八珍汤), Erzhi Pill (二至丸), and Xiaochaihu Decoction (小柴胡汤). The main development trends toward retrospective study, TCM treatment mechanism, and data mining.

Conclusion

The research on TCM treatment of ITP has progressed steadily, but in-depth studies and close cooperation between research institutions are necessary for the modernization of TCM in treating ITP.

目的通过文献计量学和可视化分析中医药治疗免疫性血小板减少症(ITP)的相关研究,梳理该领域的整体研究进展、热点和趋势,为进一步开展ITP研究提供参考。方法从中国知网(CNKI)、万方数据库、中国科技期刊数据库(VIP)、Web of Science Core Collection (WOSCC)和PubMed检索中药治疗ITP的相关文献。检索时间为数据库建立至2022年7月31日。利用VOSviewer、CiteSpace、Carrot2、NoteExpress对论文数量、类型、期刊进行数据分析,并对研究热点、作者、机构、关键词进行可视化。结果共纳入中文文献1 493篇,英文文献40篇。中文文章以临床试验研究和临床经验总结为主,英文文章以临床试验研究和动物研究为主。中文论文发表在317种中文期刊,英文论文发表在29种英文期刊。研究热点包括ITP的临床辨证、中药复方治疗ITP的疗效、ITP的治疗机制等。关键词分析表明,中西医结合治疗、临床研究、名医经验、中医治疗、细胞免疫、体液免疫等方面的研究成果较多。中文和英文文章最多的作者分别是陈欣怡教授和马柔教授,文章最多的研究机构是北京中医药大学东直门医院和中国中医科学院西苑医院。临床上常用于治疗ITP的中草药包括仙河草(agrioniae Herba)、女贞子(liustri Lucidi Fructus)、莫汉连(Mohanlian)、中介风(sarcandae Herba)等,通常用于治疗ITP的处方包括桂皮汤()、西椒地黄汤()、八珍汤()、二栀丸()和小柴胡汤()。主要发展趋势为回顾性研究、中医治疗机制和数据挖掘。结论中药治疗ITP的研究稳步推进,但中药治疗ITP的现代化还需要深入研究和各研究机构的密切合作。
{"title":"Visual analysis of research hotspots and trends in the treatment of immune thrombocytopenia with traditional Chinese medicine","authors":"Gao Yao ,&nbsp;Wu Zhenhui ,&nbsp;Wu Min ,&nbsp;Abid Naeem ,&nbsp;Li Weizhizi ,&nbsp;Zhang Daling ,&nbsp;Liu Fan ,&nbsp;Zeng Yingjian","doi":"10.1016/j.dcmed.2022.10.009","DOIUrl":"10.1016/j.dcmed.2022.10.009","url":null,"abstract":"<div><h3>Objective</h3><p>Through bibliometrics and visual analysis of the related studies on traditional Chinese medicine (TCM) treatment of immune thrombocytopenia (ITP), this study aims to sort out the overall research progress, hotspots, and trends in this field, and provide reference for further research in ITP.</p></div><div><h3>Methods</h3><p>The articles on ITP treated by TCM were retrieved from China National Knowledge Infrastructure (CNKI), Wanfang Database, China Science and Technology Journal Database (VIP), Web of Science Core Collection (WOSCC), and PubMed. The retrieval time was from the establishment of the databases to July 31, 2022. VOSviewer, CiteSpace, Carrot2, and NoteExpress were used for data analysis of the articles in terms of their quantities, types, and journals, and for visualization of research hotspots, authors, institutions, and keywords.</p></div><div><h3>Results</h3><p>1 493 Chinese articles and 40 English articles were included. The articles in Chinese mainly focus on clinical trial research and clinical experience summary, while the English articles mainly focus on clinical trial research and animal research. The Chinese articles were published in 317 Chinese journals, while English articles were published in 29 English journals. Research hotspots include the clinical syndrome differentiation of ITP, the therapeutic effect of TCM compounds on ITP, and the mechanism of ITP treatment. Keyword analysis shows that there are many research achievements in integrated traditional Chinese and western medicine treatment, clinical research, famous doctors’ experience, TCM treatment, cellular immunity, and humoral immunity. The authors with the most articles in Chinese and English are Professor CHEN Xinyi and Professor MA Rou, respectively, and the research institutions with the most articles are Dongzhimen Hospital of Beijing University of Chinese Medicine and Xiyuan Hospital of China Academy of Chinese Medical Sciences. Chinese herbs often used to treat ITP clinically include Xianhecao (Agrimoniae Herba), Nvzhenzi (Ligustri Lucidi Fructus), Mohanlian (Ecliptae Herba), Zhongjiefeng (Sarcandrae Herba), etc., and the prescription usually used to treat ITP include Guipi Decoction (归脾汤), Xijiao Dihuang Decoction (犀角地黄汤), Bazhen Decoction (八珍汤), Erzhi Pill (二至丸), and Xiaochaihu Decoction (小柴胡汤). The main development trends toward retrospective study, TCM treatment mechanism, and data mining.</p></div><div><h3>Conclusion</h3><p>The research on TCM treatment of ITP has progressed steadily, but in-depth studies and close cooperation between research institutions are necessary for the modernization of TCM in treating ITP.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000568/pdfft?md5=26ec3e3a10a8d0bb24ce4c96c76bbd17&pid=1-s2.0-S2589377722000568-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88885097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Dietary silymarin ameliorating reproductive and lactation performance of sows via regulating body antioxidant and metabolism 饲粮水飞蓟素通过调节机体抗氧化和代谢改善母猪的繁殖和泌乳性能
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.005
Wei Liangkai , Hou Gaifeng , Long Cimin , Chen Fengming , Bai Xinliang , Li Rui , Yin Yulong

Objective

The experiment was conducted to explore the effects of silymarin on reproductive and lactation performance, serum antioxidants, and body metabolism of sows.

Methods

Sixty pregnant sows (85 d, Large × Landrace) with similar genetic background, body condition, and parity were randomly divided into three groups, and each group has 20 individually housed sows. The sows in the control group (CG) were fed with basal diet, and those in the experimental group A (EGA) and B (EGB) were fed with basal diet containing 250 and 500 mg/kg silymarin, respectively. The experiment lasted 46 days from day 85 of gestation to the end of lactation (weaning on day 17 ).The milk composition and serum biochemical parameters were determined by a milk composition analyzer and a blood biochemical analyzer, respectively. Serum antioxidant indexes and plasma hormone levels were measured using the biochemical kits. The gas chromatograph was applied to detect the fecal short chain fatty acids.

Results

Compared with the CG, the total feed intake (TFI) and average daily feed intake (ADFI) were significantly increased (P < 0.01), and the urea content in regular milk tended to increase (P = 0.095) in the EG. The serum malondialdehyde (MDA) contents were decreased on day 90 of gestation and the day of farrowing (P < 0.01), and the serum contents of total antioxidant capacity (T-AOC) tended to increase on day 17 of lactation (P = 0.099) compared with the CG. Compared with the CG, the serum triglyceride (TG) concentrations in the EG tended to increase on day 90 of gestation (P = 0.062), and the content of serum total protein (TP) and albumin (ALB) reduced on day 17 of lactation (P < 0.01). Compared with the CG, plasm D-lactic acid content was decreased (P < 0.05), and the plasma prostaglandin (PG) level tended to increase (P = 0.088) in the EG on the day of farrowing and day 17 of lactation. Compared with the CG, fecal isobutyric acid concentration in the EG significantly decreased on the day of farrowing ( P < 0.05).

Conclusion

Adding 250 – 500 mg/kg silymarin to diets from the late gestation to the end of lactation could improve reproductive and lactation performance of sows via the regulation of nutrient metabolism and serum antioxidant.

目的研究水飞蓟素对母猪繁殖和泌乳性能、血清抗氧化剂及机体代谢的影响。方法选用遗传背景、体况、胎次相近的85日龄大×长母猪60头,随机分为3组,每组20头。对照组(CG)饲喂基础饲粮,试验A组(EGA)和B组(EGB)分别饲喂添加250和500 mg/kg水飞蓟素的基础饲粮。试验期为46 d,从妊娠第85天至泌乳结束(第17天断奶)。采用乳成分分析仪和血液生化分析仪分别测定乳汁成分和血清生化参数。采用生化试剂盒检测血清抗氧化指标和血浆激素水平。采用气相色谱法测定粪便中的短链脂肪酸。结果与对照组相比,总采食量(TFI)和平均日采食量(ADFI)显著提高(P <0.01),普通乳尿素含量有升高的趋势(P = 0.095)。血清丙二醛(MDA)含量在妊娠第90天和分娩当天下降(P <血清总抗氧化能力(T-AOC)含量在泌乳第17天有升高的趋势(P = 0.099)。与CG相比,EG仔猪血清甘油三酯(TG)浓度在妊娠第90天有升高的趋势(P = 0.062),血清总蛋白(TP)和白蛋白(ALB)含量在妊娠第17天降低(P <0.01)。与CG相比,血浆d -乳酸含量降低(P <0.05),泌乳第17天泌乳仔猪血浆前列腺素(PG)水平有升高趋势(P = 0.088)。与CG相比,EG的粪便异丁酸浓度在分娩当天显著降低(P <0.05)。结论妊娠后期至泌乳期末饲粮中添加250 ~ 500 mg/kg水飞蓟素可通过调节营养物质代谢和血清抗氧化来改善母猪的繁殖和泌乳性能。
{"title":"Dietary silymarin ameliorating reproductive and lactation performance of sows via regulating body antioxidant and metabolism","authors":"Wei Liangkai ,&nbsp;Hou Gaifeng ,&nbsp;Long Cimin ,&nbsp;Chen Fengming ,&nbsp;Bai Xinliang ,&nbsp;Li Rui ,&nbsp;Yin Yulong","doi":"10.1016/j.dcmed.2022.10.005","DOIUrl":"10.1016/j.dcmed.2022.10.005","url":null,"abstract":"<div><h3>Objective</h3><p>The experiment was conducted to explore the effects of silymarin on reproductive and lactation performance, serum antioxidants, and body metabolism of sows.</p></div><div><h3>Methods</h3><p>Sixty pregnant sows (85 d, Large × Landrace) with similar genetic background, body condition, and parity were randomly divided into three groups, and each group has 20 individually housed sows. The sows in the control group (CG) were fed with basal diet, and those in the experimental group A (EGA) and B (EGB) were fed with basal diet containing 250 and 500 mg/kg silymarin, respectively. The experiment lasted 46 days from day 85 of gestation to the end of lactation (weaning on day 17 ).The milk composition and serum biochemical parameters were determined by a milk composition analyzer and a blood biochemical analyzer, respectively. Serum antioxidant indexes and plasma hormone levels were measured using the biochemical kits. The gas chromatograph was applied to detect the fecal short chain fatty acids.</p></div><div><h3>Results</h3><p>Compared with the CG, the total feed intake (TFI) and average daily feed intake (ADFI) were significantly increased (<em>P</em> &lt; 0.01), and the urea content in regular milk tended to increase (<em>P</em> = 0.095) in the EG. The serum malondialdehyde (MDA) contents were decreased on day 90 of gestation and the day of farrowing (<em>P</em> &lt; 0.01), and the serum contents of total antioxidant capacity (T-AOC) tended to increase on day 17 of lactation (<em>P</em> = 0.099) compared with the CG. Compared with the CG, the serum triglyceride (TG) concentrations in the EG tended to increase on day 90 of gestation (<em>P</em> = 0.062), and the content of serum total protein (TP) and albumin (ALB) reduced on day 17 of lactation (<em>P</em> &lt; 0.01). Compared with the CG, plasm D-lactic acid content was decreased (<em>P</em> &lt; 0.05), and the plasma prostaglandin (PG) level tended to increase (<em>P</em> = 0.088) in the EG on the day of farrowing and day 17 of lactation. Compared with the CG, fecal isobutyric acid concentration in the EG significantly decreased on the day of farrowing ( <em>P</em> &lt; 0.05).</p></div><div><h3>Conclusion</h3><p>Adding 250 – 500 mg/kg silymarin to diets from the late gestation to the end of lactation could improve reproductive and lactation performance of sows via the regulation of nutrient metabolism and serum antioxidant.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000520/pdfft?md5=f9c3c5cce0e23351bb103e327c36a23b&pid=1-s2.0-S2589377722000520-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85699500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Compound Chaijin Jieyu Tablets ameliorating insomnia complicated with depression by improving synaptic plasticity via regulating orexin A, melatonin, and acetylcholine contents 复方柴金解郁片通过调节食欲素A、褪黑素、乙酰胆碱含量,改善突触可塑性,改善失眠合并抑郁
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.007
H.A.N. Yuanshan , L.I.A.O. Xiaolin , R.E.N. Tingting , W.A.N.G. Yeqing , L.I. Zirong , Z.O.U. Manshu , W.A.N.G. Yuhong

Objective

To investigate the efficacy and mechanism of action of Compound Chaijin Jieyu Tablets (复方柴金解郁片, CCJJYT) in rats with insomnia complicated with depression.

Methods

Seventy-two Sprague-Dawley rats were randomly assigned into eight groups: the control, chronic unpredictable mild stress (CUMS), sleep deprivation (SD), CUMS + SD, positive drug (venlafaxine hydrochloride + diazepam), CCJJYT high-dose (CCJJYT˗2×), medium-dose (CCJJYT˗1×), and low-dose (CCJJYT˗0.5×) groups, with nine rats in each group. Depression-like behavior was evaluated by body weight, food intake, and behavioral tests such as the sucrose preference test (SPT), open field test (OFT), forced swimming test (FST), and pentobarbital-induced sleep test (PST). Hematoxylin-eosin (HE) staining and Golgi-Cox staining were used to observe changes in pathological tissue and synaptic morphology, respectively. Enzyme-linked immunosorbent assay (ELISA) was used to detect the contents of orexin-A and acetylcholine. The expression levels of orexin receptor 1 (OXR1), melatonin receptor 1 (MT1A), melatonin receptor 2 (MT1B), acetylcholinesterase (AChE), and choline acetyltransferase (ChAT) were detected by immunohistochemistry and Western blot.

Results

In the present study, rats in the model group showed significant behavioral changes as well as a reduction in hippocampal dendritic branch length and synaptic number, along with increasing the content of orexin A and acetylcholine (P< 0.05), and altered expression levels of OX1R, MT1A, MT1B, ChAT, and AChE in the hippocampus and prefrontal cortex after modeling (P < 0.05). CCJJYT can improve depressive insomnia behavior and synaptic plasticity of rats (P < 0.05), which is similar to that of the positive drug group. It can also decrease the content of orexin A and acetylcholine, and reduce the expression levels of OXR1 and ChAT in hippocampus and prefrontal cortex (P < 0.05), and increase the expression levels of MT1A, MT1B, and AChE proteins (P < 0.05).

Conclusion

CCJJYT has good antidepressant and insomnia effects, probably through the regu-lation of orexin-A, melatonin, and acetylcholine content in hippocampus and prefrontal cortex of rats, improving synaptic plasticity and thus exerting antidepressant and insomnia effects.

目的探讨复方柴金解郁片对失眠合并抑郁大鼠的疗效及作用机制。方法将72只SD - dawley大鼠随机分为8组:对照组、慢性不可预知轻度应激(CUMS)组、睡眠剥夺(SD)组、CUMS + SD组、阳性药物组(盐酸文拉辛+地西安定)、CCJJYT高剂量组(CCJJYT巨鼠)、中剂量组(CCJJYT巨鼠)、低剂量组(CCJJYT巨鼠),每组9只。抑郁样行为通过体重、食物摄入量和行为测试(如蔗糖偏好测试(SPT)、露天测试(OFT)、强迫游泳测试(FST)和戊巴比妥诱导睡眠测试(PST))来评估。采用苏木精-伊红(HE)染色和高尔基-考克斯染色分别观察病理组织和突触形态的变化。采用酶联免疫吸附法(ELISA)检测食欲素a和乙酰胆碱的含量。免疫组织化学和Western blot检测各组小鼠食欲素受体1 (OXR1)、褪黑素受体1 (MT1A)、褪黑素受体2 (MT1B)、乙酰胆碱酯酶(AChE)、胆碱乙酰转移酶(ChAT)的表达水平。结果在本研究中,模型组大鼠表现出明显的行为改变,海马树突分支长度和突触数量减少,食欲素a和乙酰胆碱含量增加(P<0.05),造模后海马和前额叶皮层中OX1R、MT1A、MT1B、ChAT和AChE的表达水平发生改变(P <0.05)。CCJJYT可改善大鼠抑郁性失眠行为及突触可塑性(P <0.05),与阳性用药组相似。还能降低食欲素A和乙酰胆碱的含量,降低海马和前额皮质OXR1和ChAT的表达水平(P <0.05), MT1A、MT1B、AChE蛋白表达水平升高(P <0.05)。结论ccjjyt具有良好的抗抑郁和失眠作用,可能是通过调节大鼠海马和前额叶皮层食欲素- a、褪黑素和乙酰胆碱含量,改善突触可塑性,从而发挥抗抑郁和失眠作用。
{"title":"Compound Chaijin Jieyu Tablets ameliorating insomnia complicated with depression by improving synaptic plasticity via regulating orexin A, melatonin, and acetylcholine contents","authors":"H.A.N. Yuanshan ,&nbsp;L.I.A.O. Xiaolin ,&nbsp;R.E.N. Tingting ,&nbsp;W.A.N.G. Yeqing ,&nbsp;L.I. Zirong ,&nbsp;Z.O.U. Manshu ,&nbsp;W.A.N.G. Yuhong","doi":"10.1016/j.dcmed.2022.10.007","DOIUrl":"10.1016/j.dcmed.2022.10.007","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the efficacy and mechanism of action of Compound Chaijin Jieyu Tablets (复方柴金解郁片, CCJJYT) in rats with insomnia complicated with depression.</p></div><div><h3>Methods</h3><p>Seventy-two Sprague-Dawley rats were randomly assigned into eight groups: the control, chronic unpredictable mild stress (CUMS), sleep deprivation (SD), CUMS + SD, positive drug (venlafaxine hydrochloride + diazepam), CCJJYT high-dose (CCJJYT˗2×), medium-dose (CCJJYT˗1×), and low-dose (CCJJYT˗0.5×) groups, with nine rats in each group. Depression-like behavior was evaluated by body weight, food intake, and behavioral tests such as the sucrose preference test (SPT), open field test (OFT), forced swimming test (FST), and pentobarbital-induced sleep test (PST). Hematoxylin-eosin (HE) staining and Golgi-Cox staining were used to observe changes in pathological tissue and synaptic morphology, respectively. Enzyme-linked immunosorbent assay (ELISA) was used to detect the contents of orexin-A and acetylcholine. The expression levels of orexin receptor 1 (OXR1), melatonin receptor 1 (MT1A), melatonin receptor 2 (MT1B), acetylcholinesterase (AChE), and choline acetyltransferase (ChAT) were detected by immunohistochemistry and Western blot.</p></div><div><h3>Results</h3><p>In the present study, rats in the model group showed significant behavioral changes as well as a reduction in hippocampal dendritic branch length and synaptic number, along with increasing the content of orexin A and acetylcholine (<em>P</em>&lt; 0.05), and altered expression levels of OX1R, MT1A, MT1B, ChAT, and AChE in the hippocampus and prefrontal cortex after modeling (<em>P</em> &lt; 0.05). CCJJYT can improve depressive insomnia behavior and synaptic plasticity of rats (<em>P</em> &lt; 0.05), which is similar to that of the positive drug group. It can also decrease the content of orexin A and acetylcholine, and reduce the expression levels of OXR1 and ChAT in hippocampus and prefrontal cortex (<em>P</em> &lt; 0.05), and increase the expression levels of MT1A, MT1B, and AChE proteins (<em>P</em> &lt; 0.05).</p></div><div><h3>Conclusion</h3><p>CCJJYT has good antidepressant and insomnia effects, probably through the regu-lation of orexin-A, melatonin, and acetylcholine content in hippocampus and prefrontal cortex of rats, improving synaptic plasticity and thus exerting antidepressant and insomnia effects.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000544/pdfft?md5=fc28a738cd59e1136d5aed602a693902&pid=1-s2.0-S2589377722000544-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88219253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Living fossils unearthed by blasting human chromosomes with Neanderthal mtDNA 用尼安德特人mtDNA爆破人类染色体而出土的活化石
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.012
Jia Zhang , Cuilan Zhou , Li Xiao , Qinhui Tuo , Cuiying Peng , Zifen Guo , Duanfang Liao , Kai Li

The successful retrieval of ancient mitochondrial DNA (mtDNA) from Neanderthals provides powerful experimental evidence that clarifies the arguments between the out-of-Africa and multiregional models of evolution. However, the lack of nuclear DNA from Neanderthal fossils and mtDNA of early modern human fossils dating back to approximately the same time in the Pleistocene constitutes a limitation that may compromise the significance of mtDNA phylogenetic analysis. In this report, we introduce a mitochromic analysis using Neanderthal mtDNA as a foreign transgene and humans as a naturally occurring transgenic species. Forty Neanderthal mtDNA retrievable nuclear fragments were identified by blasting human genome data with Neanderthal mtDNA. Five of the 40 fragments exhibited higher correlation with Neanderthal mtDNA than those with modern human mtDNA. Furthermore, these five nuclear fragments harbor Neanderthal mtDNA-unique haplotypes. Based on the 98%+ identity between Neanderthal and modern human mtDNA when compared by groups, we suggest that some of the modern human nuclear fragments retrieved using Neanderthal mtDNA may aid in decoding Neanderthal genetic information, and also may simultaneously demonstrate a close genetic evolutionary relationship between modern humans and Neanderthals.

从尼安德特人身上成功提取的古代线粒体DNA (mtDNA)提供了强有力的实验证据,澄清了非洲外进化模式和多区域进化模式之间的争论。然而,由于缺乏尼安德特人化石的核DNA和可以追溯到更新世大约同一时期的早期现代人类化石的mtDNA,这可能会损害mtDNA系统发育分析的意义。在本报告中,我们将尼安德特人mtDNA作为外源转基因,将人类作为自然存在的转基因物种,进行线粒体染色分析。通过用尼安德特人mtDNA爆破人类基因组数据,鉴定了40个尼安德特人mtDNA可检索的核片段。在40个片段中,有5个片段与尼安德特人mtDNA的相关性高于与现代人mtDNA的相关性。此外,这五个核片段含有尼安德特人mtdna特有的单倍型。基于尼安德特人和现代人mtDNA 98%以上的同一性,我们认为使用尼安德特人mtDNA检索的一些现代人核片段可能有助于解码尼安德特人的遗传信息,同时也可能证明现代人和尼安德特人之间存在密切的遗传进化关系。
{"title":"Living fossils unearthed by blasting human chromosomes with Neanderthal mtDNA","authors":"Jia Zhang ,&nbsp;Cuilan Zhou ,&nbsp;Li Xiao ,&nbsp;Qinhui Tuo ,&nbsp;Cuiying Peng ,&nbsp;Zifen Guo ,&nbsp;Duanfang Liao ,&nbsp;Kai Li","doi":"10.1016/j.dcmed.2022.10.012","DOIUrl":"10.1016/j.dcmed.2022.10.012","url":null,"abstract":"<div><p>The successful retrieval of ancient mitochondrial DNA (mtDNA) from Neanderthals provides powerful experimental evidence that clarifies the arguments between the out-of-Africa and multiregional models of evolution. However, the lack of nuclear DNA from Neanderthal fossils and mtDNA of early modern human fossils dating back to approximately the same time in the Pleistocene constitutes a limitation that may compromise the significance of mtDNA phylogenetic analysis. In this report, we introduce a mitochromic analysis using Neanderthal mtDNA as a foreign transgene and humans as a naturally occurring transgenic species. Forty Neanderthal mtDNA retrievable nuclear fragments were identified by blasting human genome data with Neanderthal mtDNA. Five of the 40 fragments exhibited higher correlation with Neanderthal mtDNA than those with modern human mtDNA. Furthermore, these five nuclear fragments harbor Neanderthal mtDNA-unique haplotypes. Based on the 98%+ identity between Neanderthal and modern human mtDNA when compared by groups, we suggest that some of the modern human nuclear fragments retrieved using Neanderthal mtDNA may aid in decoding Neanderthal genetic information, and also may simultaneously demonstrate a close genetic evolutionary relationship between modern humans and Neanderthals.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000593/pdfft?md5=0e362df515cd1180c58ebd31b26f71d2&pid=1-s2.0-S2589377722000593-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72862177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application regularity of medicinal and dietary substances for patients during COVID-19 rehabilitation COVID-19患者康复期间药膳使用规律
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.001
L.U.O. Binfei , H.E. Qingying , Y.I. Xingqian , L.I.U. Hongning , Z.H.U. Weifeng , W.U. Diyao , Z.H.A.N.G. Anran , Z.H.A.N.G. Xiaoping , C.H.E.N. Xiaofan

Objective

This study focused on the application regularity of medicinal and dietary substances (MDS) of traditional Chinese medicine (TCM) diet therapy during rehabilitation, in order to help patients with Corona Virus Disease 2019 (COVID-19) reduce sequelae and improve their life quality.

Methods

The official websites of the national and provincial health committees, the website of the National Administration of Traditional Chinese Medicine, the China BioMedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Wanfang Database were used to search the keywords, such as “coronavirus” “novel coronavirus pneumonia” “COVID-19” “protocol” “guideline” “consensus” and “rehabilitation period”. The search time was from the establishment of databases to July 31, 2022. The prevention and control protocols of various provinces and cities were manually supplemented and screened out. The information on the frequency, property, flavor, meridian tropism, and efficacy of MDS was collected for association rule analysis through the Apriori algorithm. Hierarchical cluster analysis was performed using the Euclidean distance and longest distance.

Results

A total of 18 protocols were screened out, including 56 lists of TCM diet therapy, and 47 kinds of MDS with a frequency of 132 times during the rehabilitation of COVID-19. Among them, six lists of diet therapy were collected from national websites, 26 from local government websites, and 24 from social and academic institution websites. The intended population can be divided into seven categories including normal recovery, lung-spleen Qi deficiency, deficiency of both Qi and Yin, spleen-stomach weakness, deficiency of Yang Qi, kidney Qi deficiency, and blood deficiency. Shanyao (Dioscoreae Rhizoma) and Lianzi (Nelumbinis Semen), followed by Dazao (Jujubae Fructus) were used most commonly in MDS, with mainly flat property, sweet flavor, and spleen and lung meridians in meridian tropism. Besides, deficiency-tonifying drugs were commonly used in MDS. Through association rule analysis, 12 groups of association MDS pairs were obtained. The pair of Yiyiren (Coicis Semen) and Chenpi (Citri Reticulatae Pericarpium) had the highest Lift value, and Yiyiren (Coicis Semen) was used most frequently in the MDS category for eliminating pathogenic factors. The results of complex network analysis showed that the core MDS were Yiyiren (Coicis Semen), Shanyao (Dioscoreae Rhizoma), Huangqi (Astragali Radix), Fuling (Poria), and Dazao (Jujubae Fructus). Three core categories were classified by cluster analysis, including the category of strengthening spleen, nourishing kidney, and grasping Qi, the category of removing phlegm, abating panting, and regulating Qi, and the category of strengthening the middle-energizer and reinforcing Qi.

Conclusion

Based on the TCM theory

目的研究中医食疗中药膳物质(MDS)在康复过程中的应用规律,以帮助2019冠状病毒病(COVID-19)患者减少后遗症,提高生活质量。方法通过国家和省卫生健康委员会官方网站、国家中医药管理局网站、中国生物医学文献数据库(CBM)、中国知网(CNKI)、中国科技期刊数据库(VIP)、万方数据库等检索“冠状病毒”、“新型冠状病毒肺炎”、“COVID-19”、“方案”、“指南”、“共识”、“康复期”等关键词。检索时间为数据库建立至2022年7月31日。人工补充筛选各省市防控方案。通过Apriori算法收集MDS的频率、性质、风味、经络性和疗效等信息进行关联规则分析。采用欧几里得距离和最长距离进行层次聚类分析。结果共筛选出18种方案,其中中医食疗方案56种,MDS 47种,频次132次。其中,从国家网站收集6份食疗清单,从地方政府网站收集26份,从社会和学术机构网站收集24份。目标人群可分为正常恢复、肺脾气虚、气阴双虚、脾胃虚弱、阳气虚、肾气虚、血虚等七类。MDS中使用最多的是山药和莲子,其次是大枣,以平性、味甜为主,脾肺经偏向经络。此外,MDS常用补虚药物。通过关联规则分析,得到12组关联MDS对。益益人(Coicis Semen)和Chenpi (Citri Reticulatae Pericarpium)对Lift值最高,且益益人(Coicis Semen)在MDS类别中用于消除致病因素的频率最高。复杂网络分析结果表明,核心MDS为薏苡仁、山药、黄芪、茯苓和大枣。通过聚类分析将其分为“健脾益肾抓气”、“化痰消气调气”和“补中益气”三个核心范畴。结论根据中医理论,在COVID-19康复期间,大多数患者因气虚而处于病原菌滞留状态。中医食疗以“补泻并举”为原则,MDS组合注重补正气和消邪。食疗主要使用性质扁平、味甘的MDS,属于补虚药,根据不同情况添加合适的MDS的祛病药。最终目的是促进肺部炎症吸收,改善肺纤维化,增强免疫力,减少后遗症的发生,提高生活质量。
{"title":"Application regularity of medicinal and dietary substances for patients during COVID-19 rehabilitation","authors":"L.U.O. Binfei ,&nbsp;H.E. Qingying ,&nbsp;Y.I. Xingqian ,&nbsp;L.I.U. Hongning ,&nbsp;Z.H.U. Weifeng ,&nbsp;W.U. Diyao ,&nbsp;Z.H.A.N.G. Anran ,&nbsp;Z.H.A.N.G. Xiaoping ,&nbsp;C.H.E.N. Xiaofan","doi":"10.1016/j.dcmed.2022.10.001","DOIUrl":"10.1016/j.dcmed.2022.10.001","url":null,"abstract":"<div><h3>Objective</h3><p>This study focused on the application regularity of medicinal and dietary substances (MDS) of traditional Chinese medicine (TCM) diet therapy during rehabilitation, in order to help patients with Corona Virus Disease 2019 (COVID-19) reduce sequelae and improve their life quality.</p></div><div><h3>Methods</h3><p>The official websites of the national and provincial health committees, the website of the National Administration of Traditional Chinese Medicine, the China BioMedical Literature Database (CBM), China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Wanfang Database were used to search the keywords, such as “coronavirus” “novel coronavirus pneumonia” “COVID-19” “protocol” “guideline” “consensus” and “rehabilitation period”. The search time was from the establishment of databases to July 31, 2022. The prevention and control protocols of various provinces and cities were manually supplemented and screened out. The information on the frequency, property, flavor, meridian tropism, and efficacy of MDS was collected for association rule analysis through the Apriori algorithm. Hierarchical cluster analysis was performed using the Euclidean distance and longest distance.</p></div><div><h3>Results</h3><p>A total of 18 protocols were screened out, including 56 lists of TCM diet therapy, and 47 kinds of MDS with a frequency of 132 times during the rehabilitation of COVID-19. Among them, six lists of diet therapy were collected from national websites, 26 from local government websites, and 24 from social and academic institution websites. The intended population can be divided into seven categories including normal recovery, lung-spleen Qi deficiency, deficiency of both Qi and Yin, spleen-stomach weakness, deficiency of Yang Qi, kidney Qi deficiency, and blood deficiency. Shanyao (Dioscoreae Rhizoma) and Lianzi (Nelumbinis Semen), followed by Dazao (Jujubae Fructus) were used most commonly in MDS, with mainly flat property, sweet flavor, and spleen and lung meridians in meridian tropism. Besides, deficiency-tonifying drugs were commonly used in MDS. Through association rule analysis, 12 groups of association MDS pairs were obtained. The pair of Yiyiren (Coicis Semen) and Chenpi (Citri Reticulatae Pericarpium) had the highest Lift value, and Yiyiren (Coicis Semen) was used most frequently in the MDS category for eliminating pathogenic factors. The results of complex network analysis showed that the core MDS were Yiyiren (Coicis Semen), Shanyao (Dioscoreae Rhizoma), Huangqi (Astragali Radix), Fuling (Poria), and Dazao (Jujubae Fructus). Three core categories were classified by cluster analysis, including the category of strengthening spleen, nourishing kidney, and grasping Qi, the category of removing phlegm, abating panting, and regulating Qi, and the category of strengthening the middle-energizer and reinforcing Qi.</p></div><div><h3>Conclusion</h3><p>Based on the TCM theory","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000489/pdfft?md5=41f613d7d19b207729768144c1943b36&pid=1-s2.0-S2589377722000489-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76547707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Qingguang’an Granules on mitochondrial autophagy of retinal ganglion cells in rats with chronic ocular hypertension 清光安颗粒对慢性高眼压大鼠视网膜神经节细胞线粒体自噬的影响
Q3 Medicine Pub Date : 2022-09-01 DOI: 10.1016/j.dcmed.2022.10.006
Tang Yu , Zhu Bingyao , Shi Jian , Liu Qianhong , Chen Lihao , Peng Qinghua , Peng Jun , Yao Xiaolei

Objective

To investigate the effect and underlying mechanism of Qingguang’an Granules (青光安颗粒剂, QGAG) on mitochondrial autophagy (mitophagy) of retinal ganglion cells (RGCs) in rats with chronic ocular hypertension (COH).

Methods

Sixty Sprague Dawley (SD) rats, half males and half females, were randomly assigned to three groups: the control, model, and QGAG (2.5 g/kg) groups, with 20 rats in each group. Rats’ model of COH was established by cauterizing episcleral veins in the model group and QGAG group. Three weeks after successful modeling, rats in the QGAG group were intragastrically administered with QGAG, while rats in the control group and the model group received an equal dose of normal saline. After three months of intragastric administration, intraocular pressure (IOP) of all rats was measured. The mitophagy was monitored by the immunofluorescence method, the mitochondrial membrane potential was measured using the JC-1 method, and the morphological changes of mitophagy in RGCs were observed by transmission electron microscopy. Meanwhile, rat RGCs were labeled using the fluorescent gold method, and RGCs density in each group was calculated. Moreover, RGCs apoptosis was observed by TdT-mediated dUTP Nick-End Labeling (TUNEL) assay. Finally, the expression levels of Parkin, optineurin, microtubule-associated protein 1 light chain 3-II/microtubule-associated protein 1 light chain 3-I (LC3-II/LC3-I), recombinant lysosomal associated membrane protein 1 (LAMP1), and B-cell lymphoma-2 (Bcl-2) in RGCs were determined by Western blot assay. The corresponding mRNAs were detected through quantitative real-time polymerase chain reaction (qRT-PCR).

Results

The QGAG reduced IOP in COH rats, and inhibited mitophagy and apoptosis of RGCs (P < 0.05). Besides, the QGAG significantly increased the expression levels of Parkin and Bcl-2 (P < 0.05), and inhibited the expression levels of optineurin, LAMP1, and LC3-II/LC3-I (P < 0.05) in RGCs of COH rats.

Conclusion

The QGAG can inhibit mitophagy in RGCs of COH rats and show a protective effect against optic nerve damage caused by glaucoma, which may be mediated through the mitophagy ubiquitination via the Parkin/PINK1-related pathway.

目的探讨清光安颗粒对慢性高眼压大鼠视网膜神经节细胞(RGCs)线粒体自噬(mitophagy)的影响及其机制。方法选用SD大鼠60只,雌雄各占1 / 2,随机分为对照组、模型组和QGAG (2.5 g/kg)组,每组20只。模型组和QGAG组采用烧灼外膜静脉的方法建立COH大鼠模型。造模成功后3周,QGAG组大鼠灌胃QGAG,对照组和模型组大鼠灌胃等量生理盐水。灌胃3个月后,测定各组大鼠眼压(IOP)。免疫荧光法监测线粒体自噬,JC-1法测定线粒体膜电位,透射电镜观察RGCs线粒体自噬的形态学变化。同时采用荧光金法标记大鼠RGCs,计算各组RGCs密度。此外,通过tdt介导的dUTP镍端标记法(TUNEL)观察RGCs的凋亡。最后,采用Western blot法检测RGCs中Parkin、optineurin、微管相关蛋白1轻链3-II/微管相关蛋白1轻链3-I (LC3-II/LC3-I)、重组溶酶体相关膜蛋白1 (LAMP1)和b细胞淋巴瘤-2 (Bcl-2)的表达水平。通过实时定量聚合酶链反应(qRT-PCR)检测相应mrna。结果QGAG可降低COH大鼠眼压,抑制RGCs的自噬和凋亡(P <0.05)。此外,QGAG显著提高了Parkin和Bcl-2的表达水平(P <0.05),抑制optinurin、LAMP1和LC3-II/LC3-I的表达水平(P <0.05)对COH大鼠RGCs的影响。结论QGAG可抑制COH大鼠RGCs的线粒体自噬,并对青光眼引起的视神经损伤具有保护作用,其机制可能是通过Parkin/ pink1相关通路介导线粒体自噬泛素化。
{"title":"Effects of Qingguang’an Granules on mitochondrial autophagy of retinal ganglion cells in rats with chronic ocular hypertension","authors":"Tang Yu ,&nbsp;Zhu Bingyao ,&nbsp;Shi Jian ,&nbsp;Liu Qianhong ,&nbsp;Chen Lihao ,&nbsp;Peng Qinghua ,&nbsp;Peng Jun ,&nbsp;Yao Xiaolei","doi":"10.1016/j.dcmed.2022.10.006","DOIUrl":"10.1016/j.dcmed.2022.10.006","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the effect and underlying mechanism of Qingguang’an Granules (青光安颗粒剂, QGAG) on mitochondrial autophagy (mitophagy) of retinal ganglion cells (RGCs) in rats with chronic ocular hypertension (COH).</p></div><div><h3>Methods</h3><p>Sixty Sprague Dawley (SD) rats, half males and half females, were randomly assigned to three groups: the control, model, and QGAG (2.5 g/kg) groups, with 20 rats in each group. Rats’ model of COH was established by cauterizing episcleral veins in the model group and QGAG group. Three weeks after successful modeling, rats in the QGAG group were intragastrically administered with QGAG, while rats in the control group and the model group received an equal dose of normal saline. After three months of intragastric administration, intraocular pressure (IOP) of all rats was measured. The mitophagy was monitored by the immunofluorescence method, the mitochondrial membrane potential was measured using the JC-1 method, and the morphological changes of mitophagy in RGCs were observed by transmission electron microscopy. Meanwhile, rat RGCs were labeled using the fluorescent gold method, and RGCs density in each group was calculated. Moreover, RGCs apoptosis was observed by TdT-mediated dUTP Nick-End Labeling (TUNEL) assay. Finally, the expression levels of Parkin, optineurin, microtubule-associated protein 1 light chain 3-II/microtubule-associated protein 1 light chain 3-I (LC3-II/LC3-I), recombinant lysosomal associated membrane protein 1 (LAMP1), and B-cell lymphoma-2 (Bcl-2) in RGCs were determined by Western blot assay. The corresponding mRNAs were detected through quantitative real-time polymerase chain reaction (qRT-PCR).</p></div><div><h3>Results</h3><p>The QGAG reduced IOP in COH rats, and inhibited mitophagy and apoptosis of RGCs (<em>P</em> &lt; 0.05). Besides, the QGAG significantly increased the expression levels of Parkin and Bcl-2 (<em>P</em> &lt; 0.05), and inhibited the expression levels of optineurin, LAMP1, and LC3-II/LC3-I (<em>P</em> &lt; 0.05) in RGCs of COH rats.</p></div><div><h3>Conclusion</h3><p>The QGAG can inhibit mitophagy in RGCs of COH rats and show a protective effect against optic nerve damage caused by glaucoma, which may be mediated through the mitophagy ubiquitination via the Parkin/PINK1-related pathway.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2589377722000532/pdfft?md5=9fc0c445d7e5ea09568df060c6b95e71&pid=1-s2.0-S2589377722000532-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75797775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Digital Chinese Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1